Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 4, 2013, Pages 364-369

  Mercer, David F ^a   Hobson, Brandy D ^b   Fischer, Ryan T ^a   Talmon, Geoffrey A ^a   Perry, Deborah A ^a   Gerhardt, Brandi K ^a   Grant, Wendy J ^a   Botha, Jean F ^a   Langnas, Alan N ^a   Quiros Tejeira, Ruben E ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cholestasis; fish oil; intestinal failure; intestinal failure associated liver disease; parenteral lipids; short bowel syndrome; total parenteral nutrition

Indexed keywords

OMEGAVEN;

ARTICLE; BIOCHEMISTRY; BIRTH WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FATTY LIVER; FEMALE; GASTROSCHISIS; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; BIOPSY; CHILD, PRESCHOOL; DISEASE PROGRESSION; FAT EMULSIONS, INTRAVENOUS; FATTY LIVER; FEMALE; FISH OILS; GASTROSCHISIS; HUMANS; HYPERBILIRUBINEMIA; INFANT; INTESTINAL DISEASES; INTESTINAL VOLVULUS; LIVER; LIVER CIRRHOSIS; MALE; NEBRASKA; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME;

EID: 84875871565     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31827e208c     Document Type: Article

References (18)

1. Goulet O, Joly F, Corriol O, et al. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009;14:256-61.
2. Mehta NM, Compher C. A.S.P.E.N. Clinical Guidelines: nutrition support of the critically ill child. JPEN J Parenter Enteral Nutr 2009;33:260-76.
3. Gura KM, Parsons SK, Bechard LJ, et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005;24:839-47.
4. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197-201.
5. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:e678-86.
6. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009;66: 698-703.
7. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009;250:395-402.
8. Soden JS, Lovell MA, Brown K, et al. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr 2010;156:327-31.
9. Dixon LR, Crawford JM. Early histologic changes in fibrosing cholestatic hepatitis C. Liver Transpl 2007;13:219-26.
10. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Path 1995;19:1409-17.
11. de Meijer VE, Gura KM, Le HD, et al. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009; 33:541-7.
12. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007;62:301-6.
13. Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastro-enterology 1993;105:1806-13.
14. Iyer KR, Spitz L, Clayton P. BAPS prize lecture: new insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. J Pediatr Surg 1998;33:1-6.
15. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant 2010; 15:330-3.
16. Charatcharoenwitthaya P, Lindor KD, Angulo P. The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease. Dig Dis Sci 2012;57:1925-31.
17. Carlisle R, Galambos JT, Warren WD. The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci 1979;24:358-62.
18. Sax HC, Talamini MA, Brackett K, et al. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 1986;100:697-704.